Two respiratory syncytial virus (RSV) vaccines, RSVPreF3+AS01 and RSVpreF, were highly effective at preventing hospital admissions and death among older adults during the 2023 to 2024 season. These ...

The M72/AS01 TB vaccine was safe for virologically suppressed adults with HIV, with no severe vaccine-related AEs reported.

Adults hospitalized with CAP face high mortality rates, particularly those with unsuppressed HIV and tuberculosis.

Topline phase 3 OPUS-1 data show VAX-31 met coprimary immunogenicity endpoints, demonstrating noninferiority and superiority for key pneumococcal serotypes.

Coadministration of the MenACYW-TT vaccine with routine pediatric immunizations is well tolerated among healthy infants and ...

People with HIV experience a significantly greater increase in multimorbidity following COVID-19 diagnosis compared with those without HIV.

An MF59-adjuvanted, higher-dose influenza vaccine improves immune responses in older adults compared with standard egg-based options.

Monica Gandhi, MD, MPH, talks meningitis vaccination & prevention strategies, high-risk populations, vaccination coverage, & ...

Meningitis incidence and mortality declined significantly in the Western Pacific Region from 1990 to 2023 following expanded vaccination initiatives.

Influenza mortality increased among US children over 25 years despite declines in other vaccine-preventable deaths.

Among neurocritical patients, older age and COPD are significant risk factors for VAP, according to a systematic review and meta-analysis.

Adults with pneumococcal meningitis of hematogenous origin face a significantly higher 30-day mortality rate than those with other sources.